
RDNT · NASDAQ
RadNet, Inc.
$70.05 -0.29 (-0.41%)
Company overview
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Exchange
- NASDAQ
- Market cap
- $5.5B
- Employees
- 11,000
- Headquarters
- Los Angeles, CA
- Website
- radnet.com
- CEO
- Howard G. Berger
- Listed
- January 3, 1997
- P/E
- -396.88
- Dividend yield
- 0.00%
Company financials
- Revenue
- $2.1B
- Gross profit
- $201M
- Operating income
- $82.3M
- EBITDA
- $323M
- Net income
- -$14.2M
- EPS
- -$0.18
- Total assets
- $3.9B
- Total debt
- $1.9B
- Gross margin
- 9.38%
- Net margin
- -0.66%
- Earnings yield
- -0.25%
Showing FY 2025